SULINDAC - THERAPEUTIC IMPLICATIONS OF THE PRODRUG PHARMACOPHORE EQUILIBRIUM

被引：61

作者：

DUGGAN, DE

机构：

来源：

关键词：

D O I：

10.3109/03602538108994035

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：325 / 337

页数：13

共 18 条

AYMARD, C ;

SEYER, L ;

CHEFTEL, JC .

AGRICULTURAL AND BIOLOGICAL CHEMISTRY, 1979, 43 (09) :1869-1872

[2]

DEBAUN JR, 1976, SCIENCE, V191, P187

[3]

DUGGAN DE, 1977, J PHARMACOL EXP THER, V201, P8

[4]

DUGGAN DE, 1972, J PHARMACOL EXP THER, V181, P563

[5] COMPARATIVE DISPOSITION OF SULINDAC AND METABOLITES IN 5 SPECIES [J].

DUGGAN, DE ;

HOOKE, KF ;

NOLL, RM ;

HUCKER, HB ;

VANARMAN, CG .

[6]

DUGGAN DE, 1980, DRUG METAB DISPOS, V8, P241

[7]

DUGGAN DE, 1977, CLIN PHARMACOL THER, V21, P326

[8]

DUGGAN DE, 1979, DRUG METAB REV, V9, P19

[9]

EGAN RW, 1979, J BIOL CHEM, V254, P3295

[10]

Ham E.A., 1972, PROSTAGLANDINS CELLU, P345